SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. In: PITerasaki, JMCecka eds. Clinical Transplants 1996. 1st ed. Los Angeles: UCLA Tissue Typing Laboratory. 1997; 1530.
  • 2
    Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby, Gilcher RO, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996; 275:9951000.MEDLINE
  • 3
    Alter MJ. Epidemiology of Hepatitis C. Hepatology 1997; 26:62S65S.MEDLINE
  • 4
    Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103:317322.MEDLINE
  • 5
    Everhart JE, Wei Y, Eng H, Charlton MR, Persing DH, Wiesner RH, Germer JJ, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999; 29:12201226.MEDLINE
  • 6
    Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203210.MEDLINE
  • 7
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation [see comments]. N Engl J Med 1996; 334:815820.MEDLINE
  • 8
    Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21:3034.MEDLINE
  • 9
    Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation [see comments]. Gastroenterology 1995; 108:10881096.MEDLINE
  • 10
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, Garcia-Herola A, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29:250256.MEDLINE
  • 11
    Berenguer J, Prieto M, Mir J, Cordoba J, Rayon M. Hepatitis C viral infection after orthotopic liver transplantation. Adv Exp Med Biol 1994; 368:173179.MEDLINE
  • 12
    Barcena R, Del Campo S, Sanroman AL, Nuno J, Zelaya R, Honrubia A, Vicente E, et al. Prospective study of hepatitis C virus infection after orthotopic liver transplantation. Transplant Proc 1997; 29:515516.MEDLINE
  • 13
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28:823830.MEDLINE
  • 14
    Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:773779.MEDLINE
  • 15
    Singh N, Gayowski T, Wannstedt CF, Marino IR, Wagener MM. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy. Clin Transplant 1996; 10:348351.MEDLINE
  • 16
    Mazzaferro V, Regalia E, Pulvirenti A, Tagger A, Andreola S, Pasquali, Baratti D, et al. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination. Transplant Proc 1997; 29:519521.MEDLINE
  • 17
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [see comments]. Hepatology 1997; 26:500504.MEDLINE
  • 18
    Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB, Wiesner R, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63:14191423.MEDLINE
  • 19
    Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, Lau JY, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110:167177.MEDLINE
  • 20
    Zein N, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing D. HCV genotypes in liver transplant recipients: distribution and one year follow-up. Liver Transpl Surg 1995; 1:335357.
  • 21
    Gretch D, Corey L, Wilson J, dela Rosa C, Willson R, Carithers R, Busch M, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994; 169:12191225.MEDLINE
  • 22
    Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, Gown A, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995; 22:19.MEDLINE
  • 23
    Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106:994999.MEDLINE
  • 24
    Terrault NA, Dailey PJ, Ferrell L, Collins ML, Wilber JC, Urdea MS, Bhandari BN, et al. Hepatitis C virus: quantitation and distribution in liver. J Med Virol 1997; 51:217224.MEDLINE
  • 25
    Germer JJ, Rys PN, Thorvilson JN, Persing DH. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 1999; 37:26252630.MEDLINE
  • 26
    Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Surg Pathol 1995; 19:14091417.
  • 27
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431435.MEDLINE
  • 28
    Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clemente G, Figueras J, et al. Liver transplantation in hepatitis C. A Spanish multi-centre experience. Eur J Gastroenterol Hepatol 1998; 10:771776.MEDLINE
  • 29
    Van Thiel DH, Fagiuoli S, Caraceni P, Nadir A, Wright HI. Recurrence of hepatitis C following liver transplantation: treatment with interferon. [Review] [16 refs]. Transplantation Sci 1994; 4(Suppl 1):S2628.
  • 30
    Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20:24S27S.MEDLINE
  • 31
    Papatheodoridis GV, Barton SG, Andrew D, Clewley G, Davies S, Dhillon AP, Dusheiko G, et al. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens [see comments]. Gut 1999; 45:427434.MEDLINE
  • 32
    Negro F, Krawczynski K, Quadri R, Rubbia-Brandt L, Mondelli M, Zarski JP, Hadengue A, et al. Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction. Hepatology 1999; 29:536542.MEDLINE
  • 33
    Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C [published erratum appears in Lancet 1993;342:504] [see comments]. Lancet 1993; 341:15011504.MEDLINE
  • 34
    Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. [Review] [97 refs]. Inf Agents Dis 1993; 2:155166.
  • 35
    Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104:580587.MEDLINE
  • 36
    Mueller AR, Platz KP, Bechstein WO, Blumhardt G, Lobeck H, Hop U, Neuhaus P, et al. Increased rejection after liver transplantation in FK 506- treated patients is associated with viral hepatitis C disease. Transplant Proc 1994; 26:36373639.MEDLINE
  • 37
    McDiarmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 1995; 20:291299.MEDLINE
  • 38
    Weppler D, Khan R, Fragulidis GP, Nery JR, Ricordi C, Tzakis AG. Status of liver and gastrointestinal transplantation at the University of Miami. Clin Transpl 1996; 8:187201.
  • 39
    Zervos XA, Weppler D, Fragulidis GP, Torres MB, Nery JR, Khan MF, Pinna AD, et al. Comparison of tacrolimus with microemulsion cyclosporin as primary immunosuppression in hepatitis C patients after liver transplantation. Transplantation 1998; 65:10441046.MEDLINE
  • 40
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation [see comments]. Am J Gastroenterol 1997; 92:14531457.MEDLINE
  • 41
    Berenguer M, Prieto M, Cordoba J, Rayon JM, Carrasco D, Olaso V, San-Juan F, et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol 1998; 28:756763.MEDLINE